Danaher Corporation $DHR Position Raised by Generation Investment Management LLP

Generation Investment Management LLP boosted its holdings in Danaher Corporation (NYSE:DHR) by 56.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,965,646 shares of the conglomerate’s stock after buying an additional 1,787,522 shares during the quarter. Danaher accounts for approximately 6.2% of Generation Investment Management LLP’s holdings, making the stock its 4th biggest position. Generation Investment Management LLP’s holdings in Danaher were worth $980,914,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Allworth Financial LP grew its stake in shares of Danaher by 12.2% in the second quarter. Allworth Financial LP now owns 5,099 shares of the conglomerate’s stock worth $1,007,000 after acquiring an additional 554 shares during the period. Addison Advisors LLC lifted its position in Danaher by 14.1% during the second quarter. Addison Advisors LLC now owns 702 shares of the conglomerate’s stock valued at $139,000 after purchasing an additional 87 shares during the period. Tillman Hartley LLC bought a new stake in Danaher in the 2nd quarter worth approximately $212,000. Compass Capital Management Inc. grew its position in Danaher by 6.7% in the 2nd quarter. Compass Capital Management Inc. now owns 281,256 shares of the conglomerate’s stock worth $55,559,000 after purchasing an additional 17,641 shares during the period. Finally, ProShare Advisors LLC raised its stake in Danaher by 11.2% during the 2nd quarter. ProShare Advisors LLC now owns 116,909 shares of the conglomerate’s stock valued at $23,094,000 after buying an additional 11,771 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.

Danaher Price Performance

NYSE DHR opened at $209.89 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The stock has a market cap of $148.26 billion, a price-to-earnings ratio of 43.28, a PEG ratio of 3.28 and a beta of 0.81. The company’s 50 day moving average is $204.02 and its two-hundred day moving average is $200.40.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the company posted $1.71 earnings per share. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s payout ratio is presently 26.39%.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Evercore ISI lifted their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. TD Cowen raised their target price on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Monday. Finally, Barclays boosted their target price on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.